Alpine Woods Capital Investors, LLC Vista Gen Therapeutics, Inc. Transaction History

Alpine Woods Capital Investors, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2018 May 09, 2018	SELL	$0.91 - $1.73 $40,950 - $77,850	-45,000 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$0.72 - $2.03 $32,400 - $91,349	45,000	45,000 $50,000

2.7M

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $623M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Alpine Woods Capital Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpine Woods Capital Investors, LLC with notifications on news.